Works matching IS 17539447 AND DT 2009 AND VI 3 AND IP 4
Results: 6
Pulmonary effects of nebivolol.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 329, doi. 10.1177/1753944709339968
- By:
- Publication type:
- Article
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 245, doi. 10.1177/1753944709338489
- By:
- Publication type:
- Article
High blood pressure in Latin America: a call to action.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 259, doi. 10.1177/1753944709338084
- By:
- Publication type:
- Article
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 309, doi. 10.1177/1753944709337056
- By:
- Publication type:
- Article
Smoking cessation pharmacotherapy.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 287, doi. 10.1177/1753944709335754
- By:
- Publication type:
- Article
Nitric oxide mechanisms of nebivolol.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2009, v. 3, n. 4, p. 317, doi. 10.1177/1753944709104496
- By:
- Publication type:
- Article